NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pat…
Medical - Diagnostics & Research
US, Fort Myers [HQ]
Ratios
15 Sheets · From 2023 to 2009Configuration
Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 51.63 | 45.92 | 44.68 | 44.83 | 47.75 | 46.76 | 43.84 | 45.22 | 46.52 | 45.99 | 48.15 | 41.83 | 38.62 | 36.86 | 41.34 | |
| Profit Margin | -7.61 | -9.61 | -2.71 | 0.11 | 3.06 | 1.30 | -2.54 | -2.34 | -0.33 | 0.95 | 1.96 | 0.94 | -1.72 | -28.30 | -14.87 | |
| Operating Margin | -5.86 | -8.62 | -0.94 | 2.02 | 4.78 | 2.55 | -5.65 | 1.05 | 1.31 | 3.63 | 2.05 | -0.48 | -2.06 | -30.04 | -18.21 | |
|
EPS Growth
|
-47.38 | -36.79 | 68.93 | 105.09 | 2,757.14 | -50.00 | -309.50 | -77.33 | 85.46 | 366.67 | 176.74 | -51.82 | -281.25 | -1,566.67 | 39.66 | |
| EPS USD | -6.47 | -8.85 | -2.75 | 0.14 | 4.00 | 2.00 | -4.19 | -7.43 | -1.08 | 2.88 | 7.97 | 3.84 | -6.96 | -116.00 | -70.00 | |
| Return on Assets (ROA) | -17.33 | -24.20 | -5.90 | 0.22 | 5.09 | 1.40 | -0.69 | -1.70 | -0.25 | 0.52 | 1.13 | 0.42 | -0.45 | -8.29 | -5.23 | |
| Return on Equity (ROE) | -39.74 | -105.36 | -19.96 | 0.71 | 9.36 | 1.87 | -1.06 | -3.07 | -0.41 | 0.82 | 1.58 | 0.60 | -0.75 | -14.45 | -9.34 | |
| Return on Invested Capital (ROIC) | -18.40 | -21.34 | -804.60 | -87.63 | 9.21 | 2.83 | -1.03 | 0.68 | 0.26 | 1.60 | 2.87 | 0.07 | -0.32 | -8.61 | -6.28 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 27.50 | 49.70 | 43.18 | 45.78 | 25.96 | 10.46 | 19.40 | 31.49 | 30.71 | 22.24 | 18.73 | 22.08 | 32.77 | 35.11 | 36.38 | |
| Debt/Equity | 63.09 | 216.43 | 146.06 | 149.38 | 47.73 | 14.04 | 29.98 | 56.90 | 51.29 | 35.05 | 26.19 | 31.43 | 55.29 | 61.21 | 64.97 | |
| Debt/EBITDA | -344.16 | -366.50 | 357.10 | 236.61 | 174.17 | -1,136.52 | 1,367.52 | 320.18 | 375.67 | 322.44 | -103.87 | -31.23 | 682.59 | -414.53 | -4,129.33 | |
|
Debt/Capitalization
|
38.68 | 68.40 | 59.36 | 59.90 | 32.31 | 12.31 | 23.06 | 36.26 | 33.90 | 25.95 | 20.75 | 23.91 | 35.61 | 37.97 | 39.38 | |
| Long-Term Debt/Capitalization | 21.28 | 30.07 | 30.66 | 25.15 | 13.17 | 8.01 | 19.42 | 28.84 | 31.94 | 23.44 | 19.01 | 23.26 | 35.30 | 37.71 | 39.16 | |
| Interest Debt per Share USD | 0.12 | 0.20 | 0.22 | 0.33 | 0.24 | 0.18 | 1.19 | 1.51 | 1.42 | 1.29 | 1.36 | 2.07 | 5.15 | 4.93 | 4.93 | |
| Debt Growth | 11.71 | 90.59 | 26.94 | 59.84 | -24.73 | -18.15 | 741.63 | 48.74 | -0.70 | 6.52 | 18.32 | 64.23 | 180.81 | -0.30 | 0.12 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 147.50 | 95.31 | 115.15 | 104.63 | 191.94 | 401.71 | 247.21 | 131.57 | 242.30 | 170.16 | 454.96 | 613.16 | 781.26 | 673.05 | 619.72 | |
| Quick Ratio | 108.43 | 69.08 | 91.94 | 89.55 | 163.98 | 370.40 | 180.65 | 113.56 | 208.89 | 142.36 | 418.22 | 550.81 | 719.37 | 620.14 | 567.40 | |
| Cash Ratio | 28.24 | 11.97 | 22.96 | 10.52 | 33.75 | 230.38 | 58.47 | 20.91 | 36.56 | 16.10 | 270.74 | 312.52 | 363.20 | 292.64 | 355.63 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 2,368.59 | 2,095.60 | 2,001.33 | 1,776.82 | 1,509.34 | 1,771.98 | 1,097.22 | 2,138.24 | 1,850.35 | 1,728.05 | 1,471.67 | 875.69 | 1,270.65 | 1,325.67 | 1,436.66 | |
| Receivables Turnover | 636.18 | 656.44 | 550.85 | 426.59 | 356.33 | 425.25 | 203.92 | 439.69 | 427.97 | 359.78 | 433.81 | 415.98 | 431.94 | 425.80 | 450.86 | |
| Payables Turnover | 723.98 | 961.61 | 951.21 | 914.73 | 831.46 | 736.50 | 215.11 | 455.09 | 530.35 | 840.75 | 423.22 | 395.50 | 1,658.78 | 386.46 | 1,706.69 | |
|
Asset Turnover
|
227.64 | 251.78 | 217.98 | 199.09 | 166.52 | 107.35 | 27.12 | 72.40 | 75.32 | 54.80 | 57.62 | 44.97 | 25.90 | 29.29 | 35.19 | |
| Fixed Turnover | 679.08 | 710.29 | 654.68 | 695.58 | 685.65 | 577.30 | 288.64 | 717.13 | 708.45 | 454.51 | 450.85 | 292.62 | 228.82 | 256.65 | 321.93 | |
| Coverage | ||||||||||||||||
| Interest Coverage | -324.48 | -417.32 | -53.26 | 105.67 | 320.93 | 238.75 | -659.84 | 25.75 | 61.05 | 161.16 | 225.59 | -30.36 | -196.64 | -10,166.47 | -1,559.81 | |
| Asset Coverage | 200 | 100 | 100 | 100 | 200 | 700 | 300 | 200 | 200 | 200 | 400 | 300 | 200 | 200 | 100 | |
| Cash Flow Coverage (CFGR) | -42.15 | -30.24 | 0.80 | -3.57 | 21.49 | 111.43 | 8.96 | 20.23 | 17.11 | 39.88 | 17.59 | 0.67 | -4.36 | -10.80 | -0.32 | |
| EBITDA Coverage | -100 | -200 | 200 | 400 | 300 | 200 | 400 | 200 | 400 | 500 | 1,000 | 400 | 800 | -5,500 | - - | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | 100 | 100 | 100 | - - | 100 | 100 | 100 | 100 | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -4.32 | -6.81 | -1.97 | 0.06 | 1.16 | 0.51 | -0.53 | -0.87 | -0.12 | 0.23 | 0.27 | 0.07 | -0.20 | -12.57 | -4.33 | |
|
Price/Earnings (P/E)
|
-2,316.63 | -1,469.20 | -5,085.91 | 171,795.32 | 8,593.81 | 19,701.78 | -18,790.52 | -11,536.48 | -81,860.00 | 43,737.59 | 36,706.81 | 140,122.08 | -49,036.82 | -795.68 | -2,308.36 | |
| Price/Earnings Growth (PEG) | -48.89 | -39.94 | 73.79 | -1,634.73 | 3.12 | -394.04 | 60.71 | -149.19 | 957.83 | -119.28 | 207.69 | -2,704.05 | 174.35 | -0.51 | 58.21 | |
|
Price/Book (P/B)
|
920.69 | 1,547.93 | 1,015.11 | 1,211.66 | 804.72 | 369.21 | 200.05 | 353.83 | 336.95 | 360.34 | 579.17 | 841.99 | 369.32 | 115.00 | 215.67 | |
| Price/Tangible Book (P/TB) | 920.69 | 1,547.93 | 1,015.11 | 1,211.66 | 804.72 | 369.21 | 200.05 | 353.83 | 336.95 | 360.34 | 579.17 | 841.99 | 369.32 | 115.00 | 215.67 | |
| Price/Sales (P/S) | 176.31 | 141.19 | 137.66 | 186.53 | 262.86 | 256.15 | 477.28 | 270.50 | 267.79 | 417.24 | 718.82 | 1,315.32 | 845.11 | 225.17 | 343.22 | |
|
Price/Cash Flow (P/CF)
|
-3,462.89 | -2,364.89 | 86,755.36 | -22,696.54 | 7,845.18 | 2,360.04 | 7,450.96 | 3,074.14 | 3,839.53 | 2,578.20 | 12,575.41 | 400,403.65 | -15,316.78 | -1,739.22 | -103,974.52 | |
| Price/Free CF (P/FCF) | -2,108.54 | -1,635.03 | -7,229.61 | -2,694.67 | 80,885.21 | 3,927.86 | 11,401.14 | 4,735.91 | 15,931.34 | 3,788.79 | 87,986.45 | -21,153.18 | -4,504.60 | -1,184.68 | -6,613.33 | |
| Price/Operating CF (P/OCF) | -3,462.89 | -2,364.89 | 86,755.36 | -22,696.54 | 7,845.18 | 2,360.04 | 7,450.96 | 3,074.14 | 3,839.53 | 2,578.20 | 12,575.41 | 400,403.65 | -15,316.78 | -1,739.22 | -103,974.52 |